KABUL: Construction work has begun on three new production units at Ovison Pharma, a pharmaceutical factory in Herat, with an investment of $30 million.
The factory has also inaugurated a new production line for intravenous fluids and injections.
According to the Herat governor’s media office, the three units will be built on a 3,000-square-metre site, each comprising five floors.
Once completed, they are expected to increase the factory’s capacity to produce various medicines in line with international standards.
The newly launched intravenous fluid production line has the capacity to manufacture 100,000 packages per day.
The investment aims to boost domestic pharmaceutical production, develop Afghanistan’s pharmaceutical industry, and reduce the country’s reliance on imported medicines.